The Pennant Group, Inc. · NASDAQ:PNTG

Steik Jason Paul sold 218 The Pennant Group, Inc. shares (Form 4)

Traded Nov 17, 2026 · Filed Nov 19, 2026

On Nov 17, 2026, Steik Jason Paul (Chief Clinical Officer) sold 218 The Pennant Group, Inc. shares at US$37.15 for US$8,098 under a trading plan, leaving 14,888 shares. Filed Nov 19, 2026 (Form 4).

Sold
218 shares
Price
US$37.15
Value
US$8,098
Holding after
14,888 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Chief Clinical Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Nov 17, 2026Common StockSale218US$37.1514,888Direct

Source

Download original · View original at SEC

Related